Evidence map›Paper›PMID 36499753›Full record

ArticleInternational journal of molecular sciences2022

Analysis of Intrinsic Breast Cancer Subtypes: The Clinical Utility of Epigenetic Biomarkers and

Ieva Sadzeviciene, Kristina Snipaitiene, Asta Scesnaite-Jerdiakova, Kristina Daniunaite, Rasa Sabaliauskaite, Aida Laurinaviciene, Monika Drobniene, Valerijus Ostapenko, Sonata Jarmalaite

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Ieva SadzevicieneInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257 Vilnius, Lithuania.ORCID 0000-0003-1953-040X
Kristina SnipaitieneInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257 Vilnius, Lithuania.
Asta Scesnaite-JerdiakovaInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257 Vilnius, Lithuania.
Kristina DaniunaiteInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257 Vilnius, Lithuania.ORCID 0000-0002-4527-0624
Rasa SabaliauskaiteNational Cancer Institute, Santariskiu St. 1, LT-08406 Vilnius, Lithuania.ORCID 0000-0002-3465-3558
Aida LaurinavicieneNational Center of Pathology, Affiliate of Vilnius University Hospital Santaros Clinics, P. Baublio St. 5, LT-08406 Vilnius, Lithuania.
Monika DrobnieneNational Cancer Institute, Santariskiu St. 1, LT-08406 Vilnius, Lithuania.
Valerijus OstapenkoNational Cancer Institute, Santariskiu St. 1, LT-08406 Vilnius, Lithuania.
Sonata JarmalaiteInstitute of Biosciences, Life Sciences Center, Vilnius University, Sauletekio Ave. 7, LT-10257 Vilnius, Lithuania.
Vilnius University · LTNational Cancer Institute · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed at analyzing the DNA methylation pattern and

Indexed as

Breast NeoplasmsTriple Negative Breast NeoplasmsBiomarkers, TumorDNA MethylationEpigenomicsFemaleHumansMutationTumor Suppressor Protein p53Biomarkers, TumorTP53 protein, humanTumor Suppressor Protein p53breast cancerDNA hypermethylationFILIP1LMT1ETP53triple-negative breast cancer

Identifiers

PMID36499753
PMCPMC9741387
OpenAlexW4311666144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.